Evogene Ltd. (EVGN) stock

EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 3/30

$0.37+0.01 (+2.77%)

Close on Nov 13, 2026Market cap $3.23MP/E 0.3Yield –

Evogene price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Evogene's price to book ratio was 2.6× on Jan 31, 2025, against 2.2× a year earlier. Over the last 5 years it ranged from 0.5× to 5.5×, with a median of 1.6×.

Price to Book Ratio at the end of each year

Period	Period end	Value	Change (pts)
2025	Jan 31, 2025	2.6×	−0.5
2024	Dec 31, 2024	3.1×	+0.7
2023	Dec 29, 2023	2.5×	+1.7
2022	Dec 30, 2022	0.8×	−0.2
2021	Dec 31, 2021	1.0×	−2.0
2020	Dec 31, 2020	3.0×	+2.3
2019	Dec 31, 2019	0.8×	+0.0
2018	Dec 31, 2018	0.7×	−0.2
2017	Dec 29, 2017	0.9×	−0.4
2016	Dec 30, 2016	1.2×	–

Where these numbers come from

Parsed from the XBRL in Evogene's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Jul 25, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EVGN.

Compare: EVGN vs CBUS · EVGN vs SNES · EVGN vs DYAI · EVGN vs PRPH · EVGN vs PTCHF

Revenue growth-30.9% · median 5.9%

Gross margin-6.3% · median 17.9%

Operating margin-364.2% · median -343.4%

Net margin-220.2% · median -429.6%

Company	Revenue	Growth
CBUS	$4.53M	+19.5%
EVGN	$3.85M	-30.9%
PRPH	$3.85M	-31.2%
DYAI	$3.09M	-7.6%
SNES	$2.78M	+20.9%
PTCHF	–	–

Company

Exchange: Nasdaq
Industry: Agricultural Chemicals
Fiscal year ends: December 31
Employees: 78
Held by institutions: 3.2%
Auditor: KOST FORER GABBAY & KASIERER
SEC CIK: 1574565

Advertisement
300 × 250

See a number that looks wrong?